Gold tier: mechanically validated evidence, with its primary source.
369 evidence items · page 3 / 15
5.2 per_100_person_yearsAmong 1825 HIV-2-infected individuals initiating antiretroviral therapy, the mortality rate was 5.2 per 100 person-years of observation over the first 24 months.
Côte d'IvoireVIH/sidapublished 2016AIDS (London, England)europe_pmcdocument of 6 observations
4.7 log10 copies/mlThe median pre-antiretroviral treatment HIV-1 RNA level was 4.7 log10 copies per milliliter among 1013 patients in the Temprano trial conducted in Côte d'Ivoire.
Côte d'IvoireVIH/sidapublished 2022BMC infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1186/s12879-022-07082-2
351 individualsA total of 351 HIV-2-infected individuals participated in this study.
Côte d'IvoireVIH/sidaobserved 2012published 2015PloS oneeurope_pmcdocument of 9 observations
4.5 per_100_person-yearsHIV incidence among regular male blood donors in Abidjan decreased from 4.5 per 100 person-years in 1992–1994 to 0.06 per 100 person-years in 2010–2012.
Côte d'IvoireVIH/sidaobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations
4.3 %HCV prevalence was 4.3% among HIV-1-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations
21.3 %Occult HBV infection prevalence was 21.3% among HBsAg-negative, anti-HBcAb-positive, anti-HBsAb-negative patients with detectable HBV DNA.
Côte d'Ivoirehépatite B · VIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations
5.2 %Among 344 HIV-infected pregnant women who conceived on antiretroviral therapy, the overall proportion of miscarriage was 5.2%.
Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6
24.6 %Of 422 HIV-2-infected patients, 104 (24.6%) were treated with an unboosted PI-based regimen.
Côte d'IvoireVIH/sidapublished 2016Journal of the International AIDS Societyeurope_pmcdocument of 6 observations
8 %Among hospitalized HIV-positive adults in West Africa, other diseases were the underlying cause of hospitalization in 8% of patients.
Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
35 yearsFour hundred seventy-seven patients had a median age of 35 years and a median CD4 count of 379 cells/mm³.
Côte d'IvoireVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 6 observations
10 %Among hospitalized HIV-positive adults in West Africa, malaria was diagnosed in 10% of patients.
Côte d'Ivoirepaludisme · VIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
20.2 %Among 344 HIV-infected pregnant women who conceived on antiretroviral therapy, the overall proportion of low birth weight (LBW) was 20.2%.
Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6
72.2 %Deep venous thrombosis (DVT) was found in 26 out of 36 HIV-infected patients, representing 72.2%.
Côte d'Ivoiredeep venous thrombosis · VIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations
60 %The most prevalent protease inhibitor resistance mutations were V47A (60%) and I54M (30%).
Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 9 observations
Stavudine-containing antiretroviral regimens were associated with severe hyperlactatemia in HIV-infected adults in Côte d'Ivoire.
Côte d'IvoireVIH/sidaobserved between April 2005 and May 2009published 2010AIDS research and human retroviruseseurope_pmcdocument of 12 observations
5.9 %HIV prevalence among first-time male blood donors in Abidjan decreased from 5.9% in 1992–1994 to 0.8% in 2010–2012.
Côte d'IvoireVIH/sidaobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations
14 %Mortality in children admitted to hospital living with HIV was 14%.
Côte d'IvoireVIH/sidapublished 2015The lancet. HIVeurope_pmcdocument of 8 observations
10.1 %HIV incidence among female sex workers who reported agreeing to sex without a condom in exchange for a large sum of money in Côte d'Ivoire was 10.1%.
Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988
0.55 per_100_person-yearsThe incidence of severe hyperlactatemia was 0.55 per 100 person-years among adults initiating antiretroviral therapy in Côte d'Ivoire between April 2005 and May 2009.
Côte d'IvoireVIH/sidaobserved between April 2005 and May 2009published 2010AIDS research and human retroviruseseurope_pmcdocument of 12 observations
47.6 %Among 273 adults newly diagnosed with HIV in Abidjan, Côte d'Ivoire, 130 (47.6%) reported at least one medical consultation for an indicator relevant for HIV test proposal between 1 month and five years prior to diagnosis.
Côte d'IvoireVIH/sidaobserved 2013–2014published 2017PloS oneeurope_pmcdocument of 5 observations
13.3 per_100_person_yearsIn patients with pre-ART CD4 cell count <200 cells/μL, incidence of severe morbidity was 13.3 per 100 person-years.
Côte d'IvoireVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 9 observations
37.9 %Overall, 36 (37.9%) HIV-2 patients presented with advanced HIV disease at their last visit.
Côte d'IvoireVIH avancé · VIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations
4 %Among hospitalized HIV-positive adults in West Africa who died, the underlying cause of death was non-specific illness or unknown cause in 4% of cases.
Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
5 %The prevalence of HIV drug resistance mutations (HIVDRM) is scored as low (≤ 5%) in all five study sites — Thailand, Vietnam, Burkina Faso, Côte d'Ivoire, and Senegal — for the three drug classes analyzed.
Burkina Faso · Côte d'Ivoire · SénégalVIH/sidapublished 2009AIDS Research and Human RetrovirusesOpenAlexdocument of 3 observations
25 %Pulmonary embolism (PE) was found in 9 out of 36 HIV-infected patients, representing 25%.
Côte d'Ivoirepulmonary embolism · VIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.